Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sayed M Riyadh

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
ACS Omega|September 2, 2025
Green Efficient Synthesis of [1,3,4]Thiadiazole-Tethered Alkoxyaryl Hydrazones: Evaluation of Antitumor Activities and Molecular Docking StudiesNahlah A Alhadhrami, Sayed M Riyadh, Mohamed S M Ahmed, et al.
Molecules (Basel, Switzerland)|January 21, 2022
Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological StudySraa Abu-Melha, Mastoura Mohamed Edrees, Musa A Said, et al.
Arabian Journal of Chemistry|July 18, 2022
Synthesis and greener pastures biological study of bis-thiadiazoles as potential Covid-19 drug candidatesMusa A Said, Sayed M Riyadh, Nadia S Al-Kaff, et al.
Current Issues in Molecular Biology|October 26, 2022
Synthesis and In Silico Study of Some New <i>bis</i>-[1,3,4]thiadiazolimines and <i>bis</i>-Thiazolimines as Potential Inhibitors for SARS-CoV-2 Main ProteaseSobhi M Gomha, Sayed M Riyadh, Magda H Abdellattif, et al.
Bioorganic Chemistry|December 15, 2025
Novel bis-Thiazolidinone -based chalcones with pyridine linker: Eco-friendly synthesis, cholinesterase and beta-amyloid inhibition potency, and molecular docking studiesSobhi M Gomha, Sami A Al-Hussain, Sayed M Riyadh, et al.
Die Naturwissenschaften|October 1, 2025
Choline hydroxide mediated eco-friendly synthesis of 5-arylidene thiazol-4(5H)-one clubbed coumarin: antimicrobial evaluation and in silico studiesMuneera S M Al-Saleem, Jehan Y Al-Humaidi, Ahmed A Elhenawy, et al.
ACS Omega|September 25, 2023
Synthesis, Biological Evaluation, and Molecular Docking of Novel Azolylhydrazonothiazoles as Potential Anticancer AgentsJehan Y Al-Humaidi, Sobhi M Gomha, Sayed M Riyadh, et al.
Drug Development Research|April 2, 2026
Design, Synthesis, In Silico Profiling, and In Vitro Anticancer Assessment of Azine-Linked Thiazolo[3,2-a]benzimidazoles as CDK2-Directed Therapeutic CandidatesMohamed S M Ahmed, Sayed M Riyadh, Mohammad Alhilal, et al.
Expert Opinion on Therapeutic Patents|April 15, 2026
A patent review of VEGFR-2 inhibitors: an update (2022 - present)Thoraya A Farghaly, Marwa F Harras, Amani M R Alsaedi, et al.
Bioorganic Chemistry|May 9, 2017
Rational design, synthesis, pharmacophore modeling, and docking studies for identification of novel potent DNA-PK inhibitorsSaleh Ihmaid, Hany E A Ahmed, Adeeb Al-Sheikh Ali, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
ACS Omega|September 2, 2025
Green Efficient Synthesis of [1,3,4]Thiadiazole-Tethered Alkoxyaryl Hydrazones: Evaluation of Antitumor Activities and Molecular Docking StudiesNahlah A Alhadhrami, Sayed M Riyadh, Mohamed S M Ahmed, et al.
Molecules (Basel, Switzerland)|January 21, 2022
Potential COVID-19 Drug Candidates Based on Diazinyl-Thiazol-Imine Moieties: Synthesis and Greener Pastures Biological StudySraa Abu-Melha, Mastoura Mohamed Edrees, Musa A Said, et al.
Arabian Journal of Chemistry|July 18, 2022
Synthesis and greener pastures biological study of bis-thiadiazoles as potential Covid-19 drug candidatesMusa A Said, Sayed M Riyadh, Nadia S Al-Kaff, et al.
Current Issues in Molecular Biology|October 26, 2022
Synthesis and In Silico Study of Some New <i>bis</i>-[1,3,4]thiadiazolimines and <i>bis</i>-Thiazolimines as Potential Inhibitors for SARS-CoV-2 Main ProteaseSobhi M Gomha, Sayed M Riyadh, Magda H Abdellattif, et al.
Bioorganic Chemistry|December 15, 2025
Novel bis-Thiazolidinone -based chalcones with pyridine linker: Eco-friendly synthesis, cholinesterase and beta-amyloid inhibition potency, and molecular docking studiesSobhi M Gomha, Sami A Al-Hussain, Sayed M Riyadh, et al.
Die Naturwissenschaften|October 1, 2025
Choline hydroxide mediated eco-friendly synthesis of 5-arylidene thiazol-4(5H)-one clubbed coumarin: antimicrobial evaluation and in silico studiesMuneera S M Al-Saleem, Jehan Y Al-Humaidi, Ahmed A Elhenawy, et al.
ACS Omega|September 25, 2023
Synthesis, Biological Evaluation, and Molecular Docking of Novel Azolylhydrazonothiazoles as Potential Anticancer AgentsJehan Y Al-Humaidi, Sobhi M Gomha, Sayed M Riyadh, et al.
Drug Development Research|April 2, 2026
Design, Synthesis, In Silico Profiling, and In Vitro Anticancer Assessment of Azine-Linked Thiazolo[3,2-a]benzimidazoles as CDK2-Directed Therapeutic CandidatesMohamed S M Ahmed, Sayed M Riyadh, Mohammad Alhilal, et al.
Expert Opinion on Therapeutic Patents|April 15, 2026
A patent review of VEGFR-2 inhibitors: an update (2022 - present)Thoraya A Farghaly, Marwa F Harras, Amani M R Alsaedi, et al.
Bioorganic Chemistry|May 9, 2017
Rational design, synthesis, pharmacophore modeling, and docking studies for identification of novel potent DNA-PK inhibitorsSaleh Ihmaid, Hany E A Ahmed, Adeeb Al-Sheikh Ali, et al.
Pageof 4